Fortrea to Present at the Evercore HealthCONx Conference

FTRE 11.26.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-12-05
Name of Upcoming Event:Evercore HealthCONx Conference
Full Press ReleaseSEC FilingsOur FTRE Tweets

About Gravity Analytica

Recent News

  • 01.23.2025 - Highlighting Fortrea’s commitment to advancing rare disease clinical research
  • 01.20.2025 - Rapid diagnostic advantages in clinical research
  • 01.20.2025 - Leveraging Technology for Vaccine Trial Surveillance

Recent Filings

  • 01.14.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.13.2025 - 144 Report of proposed sale of securities

DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) --Fortrea(Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Evercore HealthCONx Conference on Thursday, December 5, 2024 at 10:00 am ET.

The live webcast will be available to investors and other interested parties by accessing the FortreaInvestor Relations website. A webcast replay will be available after the event.

About FortreaFortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient atFortrea.comand follow us onLinkedInandX(formerly Twitter).

Fortrea Contacts:

Hima Inguva (Investors) – 877-495-0816,hima.inguva@fortrea.comSue Zaranek (Media) – 919-943-5422,media@fortrea.comKate Dillon (Media) – 646-818-9115,kdillon@prosek.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com